Tesamorelin – 5mg
$75.00
Tesamorelin
Tesamorelin is a synthetic peptide that acts as a growth hormone-releasing hormone (GHRH) analogue. It stimulates the release of growth hormone from the pituitary gland, leading to increased levels of insulin-like growth factor 1 (IGF-1). Tesamorelin has been studied for its potential applications in promoting fat loss, improving metabolic health, and addressing conditions associated with reduced growth hormone levels.
Potential Research Applications
Tesamorelin is currently being explored in research settings for its role in:
- Metabolic Function: Investigated for its potential to improve fat metabolism and reduce visceral adiposity.
- Growth Hormone Stimulation: Studied for its ability to stimulate growth hormone release and its impact on IGF-1 levels.
- Body Composition: Examined for its potential to promote fat loss while preserving lean body mass.
- Anti-Aging Research: Explored for its potential to address aspects of aging related to growth hormone deficiency.
✔ High-Quality Research Peptides – Produced under stringent quality control standards.
✔ Lab-Tested for Purity – Ensures consistency for scientific studies.
✔ Research Use Only – Not for human consumption or medical applications.
✔ Peptides – Will arrive in a lyophilized (powder) form for maximum stability and ease of reconstitution.
The peptides are available for research and laboratory purposes only. Please review and ahere to our Terms and Conditions before ordering.
- Description
- Certificate of Analysis
Tesamorelin, a synthetic peptide, stimulates growth hormone (GH) release from the pituitary gland. It modifies natural growth hormone-releasing hormone (GHRH) to enhance GH production. As a result, researchers study Tesamorelin for its potential to counteract GH decline and support metabolic health.
Moreover, Tesamorelin binds to GHRH receptors, triggering GH release from the anterior pituitary. This process, in turn, boosts fat metabolism, muscle growth, and protein synthesis. Additionally, Tesamorelin reduces visceral fat, thereby lowering risks for diabetes, heart disease, and obesity.
Furthermore, studies highlight Tesamorelin’s role in treating lipodystrophy by reducing excess visceral fat and improving insulin sensitivity. Researchers also explore its effects on body composition in individuals experiencing age-related GH decline.
Unlike traditional GH therapies, Tesamorelin stimulates natural GH release without introducing synthetic hormones. Consequently, this targeted approach helps regulate GH levels more effectively.
In addition, scientists investigate Tesamorelin’s effects on cognitive function, skin health, and aging. However, further research is still needed to confirm these benefits.
Overall, Tesamorelin remains a key research compound for metabolic health, fat loss, and GH regulation.
